Palantir's Tax Storm in Europe Threatens to Overshadow a Quarter for the Record Books
Published on 08/06/2026 at 00:50 | Redaktion boerse-global.de
The tension between Palantir's blistering commercial momentum and its simmering reputational exposure in Europe has rarely been this stark. The data-analytics firm just delivered a quarter that left Wall Street forecasts in tatters, yet a separate front is opening on the other side of the Atlantic — one that could test whether investors are willing to look past more than just the chart.
Shares of Palantir were changing hands at roughly 138 euros on Wednesday, down about 2 percent on the day as the initial euphoria faded. The pullback, though, is barely a footnote against the backdrop of the past week: the stock has still added over 28 percent in seven sessions, leaving it comfortably above its 200-day moving average.
The US Engine That Won't Quit
The catalyst for the surge was Monday's second-quarter report, which showed revenue of $1.935 billion — up 93 percent year over year and well ahead of the $1.81 billion consensus. The standout figure came from the US commercial segment, where sales jumped 149 percent to $764 million, marking the twelfth consecutive quarter of accelerating growth in that division.
That momentum translated into 220 deals worth at least $1 million each during the quarter, and management responded by lifting its full-year 2026 revenue guidance to a range of $8.150 billion to $8.158 billion, up from a prior outlook of $7.65 billion to $7.66 billion. The company also raised its adjusted free cash flow projection to between $4.5 billion and $4.7 billion.
Should investors sell immediately? Or is it worth buying Palantir?
The quality of the numbers extends beyond the top line. GAAP net income came in at $1.062 billion, good for a 55 percent margin, while adjusted earnings per share of $0.41 topped analyst estimates that had clustered between $0.34 and $0.35. Palantir also touted a "Rule of 40" score of 155 percent, supported by the 93 percent revenue growth and a 62 percent adjusted operating margin. Adding to the bullish narrative, the company disclosed a $10 million annual contract win with an unnamed major Silicon Valley technology firm, a deal it said was secured in direct competition with leading AI labs.
The balance sheet remains a fortress: $9.2 billion in cash, zero debt, and a US government business that expanded 90 percent. CEO Alex Karp's favored framing of "AI sovereignty" is looking increasingly validated by the numbers.
Wall Street Rewrites Its Script
The analyst community responded with a flurry of target-price revisions. Citigroup's Tyler Radke lifted his target to $245, having cut it to $200 just before earnings — a reversal he attributed to the quarter significantly weakening the bear case around AI competition. DA Davidson's Gil Luria moved his target from $175 to $200 while maintaining a "Buy" rating, citing record commercial bookings in the US. Rosenblatt Securities reaffirmed a $225 target with a "Buy" stance, positioning Palantir as a primary beneficiary of global AI adoption, while Cantor Fitzgerald raised its target to $156 but held steady with a neutral rating.
The European Headache That Won't Disappear
Yet even as the US story strengthens, a report from the Centre for International Corporate Tax Accountability and Research (CICTAR) has reignited a debate that could prove harder to shake than any single analyst note. The organization alleges that Palantir paid just £2 million in UK corporate tax in 2024, against £247 million in UK revenue and roughly £670 million in government contracts, including work with the NHS and the Ministry of Defence. The Guardian reported an effective global tax rate of 1.4 percent.
Critics point to profit shifting via service fees to the US as the mechanism. The arrangements may be legal, but for a company so deeply embedded with defense and healthcare institutions, the reputational calculus differs from that of an ordinary software vendor. Should the controversy escalate into regulatory action rather than remaining a headline story, the market may find it difficult to look the other way.
Institutional interest, meanwhile, continues to grow. Swedbank AB disclosed holdings of more than 4 million shares at the end of the second quarter, while the New York State Common Retirement Fund reported nearly 2.4 million shares in its latest filing.
Palantir at a turning point? This analysis reveals what investors need to know now.
A Chart That's Run Hot
The technical picture adds another layer of caution. The 14-day relative strength index sits at 68.8, just shy of the classic overbought threshold of 70, after the stock gained 19.3 percent in just 30 days. A portion of the recent explosion also traces to a short squeeze on August 4 that is estimated to have cost bears roughly $3 billion — a reminder that not all of the rally is purely fundamental.
Despite the surge, the shares remain 23.4 percent below their November 2025 record high of 179.98 euros, and the stock is still down 12.3 percent on a year-to-date basis. At roughly 38 times sales, the valuation leaves little margin for error.
The operational story is genuinely exceptional — growth rates approaching 150 percent in a single segment are rare at this scale. But with the chart overbought, the valuation stretched, and a European tax controversy simmering, the more likely near-term scenario is consolidation rather than an immediate assault on prior highs. The momentum is undeniable; whether the price has already run ahead of it is the question that now hangs over the stock.
Ad
Palantir Stock: New Analysis - 6 August
Fresh Palantir information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
